An oral cancer vaccine using Bifidobacterium vector augments combination of anti-PD-1 and anti-CTLA-4 antibodies in mouse renal cell carcinoma model. This evidence concerns the gene CTLA4 and hereditary clear cell renal cell carcinoma.